Advertisement
|
|
news roundup
IRBM, announced a new agreement in the peptide therapeutics area with Merck & Co. Inc., Kenilworth NJ USA, continuing their long-standing history of collaboration that began in 2010. This new agreement is focused on advancing peptide therapeutics.
| Advertisement
A Pan-cancer View of Immune Cell Activity, Immune Checkpoints, and Tumor Mutational Burden
Thursday, October 11, 2018 at 11am EDT
 Register Now |
The WIRB-Copernicus Group's Clinical Services Division has partnered with Inspire, an online community of patients and caregivers, to make clinical research more accessible to all patients with the use of permission-based and opt-in approaches.
| Advertisement
On the brink of change: How academic data and machine learning can revolutionize Alzheimer's drug development
Thursday, October 4, 2018 at 11am EDT
 Register Now |
The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors approved a new policy calling for the researchers PCORI funds to share their data sets and documentation for reanalysis and reuse.
| Advertisement
Artificial Intelligence: A Transformative Journey for Pharmacovigilance
Thursday, September 27, 2018 at 11am EDT
 Register Now |
Clinical researech technology provider Clinerion and Semicrol, the creator of Fundanet CTMS, will integrate the functionality of Clinerion's Patient Network Explorer with Semicrol's CTMS product.
|
|
|
| Advertisement
Challenging the Status Quo: The Diffusion of Technology in Study Startup
Tuesday, September 25, 2018 at 1pm EDT | 12pm CDT | 10am PDT
 Register Now |
| Advertisement
A Next Generation Sequencing Approach to Influenza Vaccine Development
Thursday, September 20, 2018 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
 Register Now |
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
| Advertisement
Decoding the Distinction: DMCs, CECs, and Their Role in Medical Device Research
On Demand
 Learn more |
|
|
|
Articles
Industry experts look at how the specific needs of patients come into play when conducting gene-based screenings.
How the use of M&S in cancer trials from the outset can help address those critical "what if?" scenarios and accelerate oncology drug development.
|
|
Blog Posts
Feasibility, the evaluation of whether a particular trial can recruit enough of the right patients so that the study completes on time and within budget, is arguably the most critical part of the clinical trial process.
Researchers are now looking to design their trials around a bring-your-own-device (BYOD) strategy, which allows participants in a clinical trial to provide study data using their own internet-enabled hardware.
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
